On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

COVID-19 and people who use drugs; seizing opportunity in times of chaos
COVID-19 holds the world in a tight grip. In these unprecedented times, health and health-system capacities have been on the top of the global agenda for several months. Many countries have rolled out far-reaching prevention measure such as physical distancing and ‘lock-downs’ to prevent (further) overwhelming of health system capacities. In many contexts, people who use drugs are a vulnerable population, prone to poor access to health services compounded by criminalization, and stigmatisation in health-care settings.
Covid-19 and the impact on harm reduction in Europe
Launch of the special harm reduction journal edition
The Global State of Harm Reduction 2020
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world. Now in its the seventh edition, the Global State of Harm Reduction 2020 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis.
Report on Opioid-Related Deaths during the COVID-19 Pandemic
The emergence of the COVID-19 pandemic in Ontario led the province to declare a state of emergency on March 17, 2020. Physical distancing measures intended to mitigate the spread of COVID-19 (e.g., reduced hours of operation for pharmacies, outpatient clinics, and harm reduction sites providing care to people who use drugs) may have led to unintended harms in terms of opioid-related deaths.
80% of Americans can't accurately identify opioids, study finds
While three-quarters of Americans believe they can recognize whether or not they have been prescribed an opioid, only 1 in 5 of these participants could correctly identify seven commonly prescribed opioids.
New study calculates alarming lifetime risk of death from firearms and drug overdoses in the US
A new study appearing in The American Journal of Medicine calculates the lifetime risk of death from firearms and drug overdoses in the United States.
Making the investment case: Cost-effectiveness evidence for harm reduction
This briefing compiles geographically diverse evidence to enable advocates to make the case for the cost-effectiveness of harm reduction
Patients with substance use disorder discriminated against by post-acute care facilities
New study at Boston Medical Center results show high rejection rates based on substance use disorder, medication treatment status
Share this on: